{"organizations": [], "uuid": "6d209fdb28cd0012575103499ddd8115c98655b3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180426.html", "section_title": "Archive News &amp; Video for Thursday, 26 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-jinghua-pharmaceutical-group-recei/brief-jinghua-pharmaceutical-group-receives-gmp-certificate-idUSL3N1S35XQ", "country": "US", "domain_rank": 408, "title": "Jinghua Pharmaceutical Group receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-04-26T20:00:00.000+03:00", "replies_count": 0, "uuid": "6d209fdb28cd0012575103499ddd8115c98655b3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-jinghua-pharmaceutical-group-recei/brief-jinghua-pharmaceutical-group-receives-gmp-certificate-idUSL3N1S35XQ", "ord_in_thread": 0, "title": "Jinghua Pharmaceutical Group receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "jinghua pharmaceutical group", "sentiment": "negative"}, {"name": "jinghua pharmaceutical group co ltd", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "jiangsu food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - Jinghua Pharmaceutical Group Co Ltd :\n* Says it received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration\n* Certificate issued tablets, hard capsules, granules, pills (water pills), powder, syrup, pretreatment and extraction of Chinese medicine manufactured by the company and the valid period is until April 15, 2023\nSource text in Chinese: goo.gl/ZE9kGC\n (Beijing Headline News)\n ", "external_links": ["https://goo.gl/ZE9kGC", "https://twitter.com/reuters", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://www.youtube.com/user/ReutersVideo", "https://instagram.com/reuters/"], "published": "2018-04-26T20:00:00.000+03:00", "crawled": "2018-04-27T16:28:11.101+03:00", "highlightTitle": ""}